Association of Biotechnology Led Enterprises

News

ABLE member Syngene acquires facility from Stelis Biopharma for ? 702 cr

Syngene International, a subsidiary of Biocon Ltd., has decided to acquire a Unit 3 biologics manufacturing facility in Bengaluru from Stelis Biopharma Limited (SBL) on a slump sale basis for a gross value of ?702 crore.

Jul 02, 2023

By : Team ABLE

NCBS launches Rohini Nilekani Centre for Brain and Mind for research on severe mental illnesses

Rohini Nilekani, chairperson of Rohini Nilekani Philanthropies, unveiled the plaque to mark the inauguration of the centre on the NCBS campus. In May this year, Rohini Nilekani Philanthropies announced the grant of Rs 100 crore to the NCBS and the National Institute of Mental Health and Neurosciences (NIMHANS) to set up the centre.

Jul 01, 2023

By : Team ABLE

Regulator approves first Omicron-specific mRNA vaccine from India

Gennova officials say India’s first indigenous mRNA vaccine for the Omicron variant is likely to be rolled out within two to three weeks

Jun 24, 2023

By : Team ABLE

Scientist’s Biotech Startup Converts Methane to Sustainable Products, Helps Farmers Earn More

Dr Ezhil Subbian, founder of Bengaluru-based startup String Bio, leverages biotechnology to solve the problem of sustainable food and animal feed production by employing methane, a greenhouse gas (GHG), as a resource.

Jun 16, 2023

By : Team ABLE